STRIDES PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?
STRIDES PHARMA has two hundred and sixty approved drugs.
There are three tentative approvals on STRIDES PHARMA drugs.
Summary for STRIDES PHARMA
| US Patents: | 0 |
| Tradenames: | 157 |
| Ingredients: | 153 |
| NDAs: | 260 |
| Patent Litigation for STRIDES PHARMA: | See patent lawsuits for STRIDES PHARMA |
Drugs and US Patents for STRIDES PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;ORAL | 076062-002 | Apr 23, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Strides Pharma | PIROXICAM | piroxicam | CAPSULE;ORAL | 210347-001 | Jan 26, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 090598-003 | Aug 11, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Strides Pharma | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 215312-002 | Sep 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | HALOPERIDOL | haloperidol | TABLET;ORAL | 071235-005 | Jul 20, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Strides Pharma | IBUPROFEN | ibuprofen | TABLET;ORAL | 070986-001 | Jul 25, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Strides Pharma | PREDNISONE | prednisone | TABLET;ORAL | 210785-001 | Sep 2, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for STRIDES PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 6,143,775 | ⤷ Sign Up |
| Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,482,963 | ⤷ Sign Up |
| Strides Pharma | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,319,097 | ⤷ Sign Up |
| Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | 3,524,844 | ⤷ Sign Up |
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-007 | Jun 13, 1995 | 4,215,104 | ⤷ Sign Up |
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-002 | Approved Prior to Jan 1, 1982 | 5,238,924 | ⤷ Sign Up |
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-004 | Jun 13, 1995 | 4,215,104 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 10 mg and 20 mg | ➤ Subscribe | 2008-02-29 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
